First Injectable Treatment for HIV Pre-Exposure Prevention Approved

THE United States (US) Food and Drug Administration approved Apretude or use in at-risk adults and adolescents weighing at least 35 kilograms (77 pounds) for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV. Apretude is given first as two initiation injections administered one month apart, and then every two months thereafter. Patients can either start their treatment with Apretude or take oral cabotegravir (Vocabria) for four weeks to assess how well they tolerate the drug. Own Correspondent “Today’s approval adds an important tool in the effort to…

Read More

Coronavirus Mutation Causing High False Negative Results In Zim-Lancet

NEW Coronavirus strains being reported worldwide could be the reason why most Laboratories in Zimbabwe have been recording high cases of false negative COVID-19 results of late, a top pathologist has said. By Michael Gwarisa Speaking during a virtual press briefing, Lancet Laboratories Chief Executive Officer, Dr Charlse Muronda said the viruses have changed their genetic makeup , in the process making it difficult for other  organisations which have not upgraded their testing equipment to pick the virus during testing procedures. One of the things that have happened with COVID-19…

Read More